SlideShare a Scribd company logo
1 of 26
FORMULATION AND
EVALUATION OF
MUCOADHESIVE
DRUG DELIVERY
-BY
MADHAVI GUPTA
M.PHARM 1ST SEM
PHARMACEUTICS
What is Mucoadhesive drug delivery system?
 Mucoadhesive drug delivery system interact with the mucus
layer covering the mucosal epithelial surface, & mucin
molecules & increase the residence time of the dosage form at
the site of the absorption.
 Mucoadhesive drug delivery system is a part of controlled
delivery system.
 MDDS have been developed for buccal, nasal, rectal and
vaginal routes for both systemic and local effects.
 Hydrophilic drugs having high mol. wt. such as peptides that
cannot be administered and having a poor absorption, then in
such type of cases Mucoadhesive Drug Delivery system is best
choice.
Why are we using Mucoadhesive drug delivery
system(MDDS)?
 MDDS prolong the residence time of the dosage form at the site of
application or absorption.
 Intimate contact of the dosage form with the underlying absorption .
 Improve the therapeutic performance of drug.
 Should not cause irritation.
 High drug loading capacity.
 Controlled drug release(preferably unidirectional release).
MECHANISM OF MUCOADHESION-
Formulation design-
 In case of both mucosal(local) & transmucosal (systemic)
administration of conventional dosage are not able to assure
therapeutic level.
 In MDDS contain the following functional agents-
• Mucoadhesive agents
• Penetration enhancers
• Enzyme inhibitors
Mucoadhesive agents-
 The polymer hydration & consequently the mucus cohesive
properties that promote mucoadhesion .
 Swelling should favor polymer chain flexibility &
interpenetration b/w polymer & mucin chains.
Ex-Poly acrylic acid (PAA)
Polyvinyl alcohol (PVA)
Sodium carboxy methyl cellulose (NaCMC)
Sodium alginate
HPMC
HEC
HPC
 Various copolymer of acrylic acid such as acrylic acid,
polyethylene glycol, mono methyl ether copolymer have also
been studied.
Penetration enhancers(PE)-
 Substances that facilitate the permeation through mucosa
are referred as permeation enhancers. They also required
when a drug has to reach the systemic circulation to exert its
action .
 Must be non-irritant, non toxic &have a reversible effect.
 Recently chitosan & its derivatives, polymers known for
having Mucoadhesion properties are used, chitosan helps in
transportation of drug throw paracellular pathway.
List of Permeation Enhancer :-
 Benzalkonium chloride
 Dextran sulfate
 Fatty acid
 Propylene glycol
 Menthol
 Phosphatidyl choline
 Polysorbate 80
 Sodium EDTA
Enzyme inhibitors-
 Drug + enzyme inhibitors, improves the buccal absorption
of drugs, specially peptides.
Ex-1-Aprotinin
2-Bestatin
3-Puromycin
 Bile salts stabilizes protein drugs by different mechanism
effecting the activity of the enzymes, altering the conformation
of the protein.
 Chemical modification of chitosan with EDTA produces
polymer conjugate chitosan –EDTA that is a very potent
inhibitor of metallopeptidases (carboxypeptidase)
MUCOADHESIVE DOSAGE FORM-
A) Tablets
Tablets are small, flat and oval, with a diameter of approximately 5–8
mm. They soften, adhere to the mucosa, and are retained in position
until dissolution and/or release is complete. Mucoadhesive tablets, in
general, have the potential to be used for controlled release drug
delivery, but coupling of mucoadhesive properties to tablet has
additional advantages, for example, it offers efficient absorption and
enhanced bioavailability of the drugs due to a high surface to volume
ratio and facilitates a much more intimate contact with the mucus layer.
B) Matrix tablets-
(a)Monolithic
(b)two layered tablets
 Monolithic-
mixture of drug + swelling bioadhesive polymer
bidirectional release & outer side coated with impermeable hyrophobic
substances.
 In two layered matrix tablets-
Comprises an inner layer based on bioadhesive polymer &an outer non
bioadhesive layer containing the drug for a bi-directional release but only
local action. In case of systemic action outer layer is inert & act as a
protective layer.
C) Patches-
Several different patch systems that adhere to the oral mucosa and are
designed to deliver drugs have been developed.
These patches are longer acting than solid forms such as tablets and lozenges
and can produce sustained drug release for treating oral candidiasis and
mucositis. Having greater patient compliance compared with tablets owing
to their physical flexibility that causes only minor discomfort to the patient.
C) Films-
Mucoadhesive films may be preferred over adhesive tablets in terms of
flexibility and comfort. Thin strips of polymeric films, capable of loading up
to 20 mg of drugs, dissolve on the tongue in less than 30 sec and deliver
drugs (which are able to cross the permeability barrier) directly to the blood
supply for rapid treatment of conditions such as impotence, migraines,
motion sickness, pain relief and nausea. An ideal film should be flexible,
elastic &soft, without breaking due to stress from mouth movements.
D) Gels & ointments-
Semisolid dosage forms, such as gels and ointments, have the advantage of
easy dispersion throughout the oral mucosa.. Poor retention of the gels at the
site of application has been overcome by using mucoadhesive formulations.
Mucoadhesive polymers, for example, sodium carboxymethylcellulose,
carbopol, hyaluronic acid, and xanthan gum, undergo a phase change from
liquid to semisolid. This change enhances the viscosity, which results in
sustained and controlled release of drugs.
Hydrogels are also a promising dosage form for buccal drug delivery. Gels
applied to the oral mucosa have been trilled for the delivery of systemic
analgesics, antihypertensive and drugs for treating cardiovascular disease as
well as topical delivery of antifungal agents, anti-inflammatories and
mucoprotective agents to the oral mucosa.
EVALUATION STUDIES OF MUCOADHESIVE
DRUG DELIVERY SYSTEM -
A) In vitro/ex vivo tests
• Methods determining tensile strength
• Methods determining shear stress
• Adhesion weight method
• Fluorescent probe method
• Flow channel method
• Mechanical spectroscopic method
• Falling liquid film method
• Colloidal gold staining method
• Viscometer method
• Thumb method
• Adhesion number
• Electrical conductance
• Swelling properties
• In vitro drug release studies
B) In vivo methods
• Use of radioisotopes
• Use of gamma scintigraphy
• X - ray studies
 Methods determining tensile strength
Tensile and shear measure the mechanical properties of the system, whereas
peel strength measures the peeling force.
Texture profile analyzer is a commercial instrument which is used to measure
the force required to remove bioadhesive films from excised tissue in vitro.
For this test, a piece of animal mucous membrane was taken and tested for
the force required to take away the formulation from a model membrane
which consists of disc composed of mucin.
The texture analyzer, operating in tensile test mode and coupled with a
sliding lower platform, was also used to determine peel strength of similar
formulations. On a movable platform the animal skin was placed and on top
of it the bioadhesive film was placed, which was later on pulled vertically to
determine the peel strength.
Texture profile analyzer in bioadhesion
test mode
Determines peel strength of
bioadhesive films
 Methods determining shear stress
The measurement of the shear stress gives a direct correlation to the adhesion
strength. In a simple shear stress measurement based method two smooth,
polished plexi glass boxes are taken. one block is fixed with adhesive
Araldite on a glass plate, which is fixed on leveled table. The level is
adjusted with the spirit level. To the upper block, a thread is tied and the
thread is passed down through a pulley, the length of the thread from the
pulley to the pan was 12 cm. At the end of the thread a pan of fixed is
attached. More weights can be added to it. A recent method involves the
measurement of mucoadhesion by use of a stainless steel rotating cylinder
which is coated with freshly excised porcine intestinal mucosa to which
polymer discs were attached. The cylinder is placed in a dissolution
apparatus and rotated at 125 RPM. It is analysed every 30 mins for the
attachment of the polymers discs.
 Falling liquid film method
In this method the mucous membrane is placed in a stainless steel cylindrical
tube, which has been longitudinally cut. This support is placed inclined in a
cylindrical cell with a temperature controlled at 37º. An isotonic solution is
pumped through the mucous membrane and collected in a beaker.
 Fluorescent probe method
In this method the membrane lipid bilayer and membrane proteins are labeled
with pyrene and fluorescein isothiocyanate, respectively. The cells are mixed
with the mucoadhesive agents and changes in fluorescence spectra were
monitored. This gives an indication of polymer binding and its influence on
polymer adhesion
 Flow Channel method
The method is conducted to understand structural requirements for
bioadhesion in order to design improved bioadhesive polymers for oral use.
The membrane lipid bilayer and membrane proteins were labeled with pyrene
and fluorescence isothiocyanate, respectively. The cells were then mixed with
candidate bioadhesives and the change in florescence spectra was monitored.
This gave an indication of polymer binding and its influence on polymer
adhesion.
 Swelling index
The extent of swelling can be measured in terms of % weight gain by the
dosage form. The swelling index is calculated using following formula.
Where, S.I = Swelling index
Wt = Weight of tablet at time t
Wo = Weight of tablet before placing in the beaker
 Colloidal gold staining method
Colloidal gold staining technique is proposed for the study of bioadhesion.
The technique employs red colloidal gold particles, which are adsorbed on
mucin molecules to form mucin–gold conjugates, which upon interaction
with bioadhesives hydrogels develops a red color on the surface. This can
be quantified by measuring either the intensity on the hydrogel surface or
the conjugates at 525 nm.
 Viscometric method
A simple viscometric method is used to quantify mucin – polymer
bioadhesive bond strength. Viscosities of 15% w/v porcine gastric mucin
dispersion in 0.1M HCl (pH 1) or 0.1M acetate buffer (pH 5.5) is measured
with a Brookfield viscometer in the absence or presence of selected neutral,
anionic, and cationic polymers. Viscosity components and the forces of
bioadhesion are calculated.
 Thumb method
This is a very simple test used for the qualitative determination of peel
adhesive strength of the polymer and is useful tool in the development of
buccal adhesive delivery systems. The adhesiveness is measured by the
difficulty of pulling the thumb from the adhesive as a function of the
pressure and the contact time.
 Adhesion number
Adhesion number for mucoadhesive microspheres is determined as the ratio
of the number of particles attached to the substrate to the total number of
applied particles, expressed as a percentage. The adhesion strength increases
with an increase in the adhesion number.
 Electrical conductance
The rotational viscometer was modified to determine electrical conductance
of various semi-solid mucoadhesive ointments and found that the electrical
conductance was low in the presence of adhesive material.
 Mucoadhesive Strength
Mucoadhesive strength of the dosage form can be measured on the modified
physical balance. The apparatus consists of a modified double beam physical
balance in which the right pan is replaced by a glass slide with copper wire and
additional weight, to make the right side weight equal with left side pan. A
Teflon block of fixed diameter and height is fabricated with an upward portion
of 2 cm height and 1.5 cm diameter on one side. This is kept in beaker filled
with buffer media 0.1N HCl pH 1.2, which is then placed below right side of the
balance. Goat or rat stomach mucosa can be used as a model membrane and
buffer media 0.1N HCl pH 1.2 can be used as moistening fluid. The one side of
the dosage form is attached to the glass slide of the right arm of the balance and
then the beaker is raised slowly until contact between goat mucosa and
mucoadhesive dosage form is established. A preload of 10 g is placed on the
slide for 5 min (preload time) to establish adhesion bonding between
mucoadhesive dosage form and stomach mucosa. The preload and preload time
are kept constant. After the completion of preload time, preload is removed from
the glass slide and water is then added in the plastic bottle in left side arm by
peristaltic pump at a constant rate of 100 drops per min. The addition of water is
stopped when mucoadhesive dosage form is detached from the goat or rat
stomach mucosa. The weight of water required to detach mucoadhesive dosage
form from stomach mucosa is noted as mucoadhesive strength in grams.
Figure : Mucoadhesion test assembly
Mdds
 Stability Studies
The success of an effective formulation can be evaluated only through
stability studies. The purpose of stability testing is to obtain a stable product
which assures its safety and efficacy up to the end of shelf life at defined
storage conditions and peak profile. ICH guidelines can be followed in this
regard.
In vivo Studies-
 Measurement of the Residence Time-
Measurements of the residence time of mucoadhesive at the application site
provide quantitative information on their mucoadhesive properties. The GI
transit times of many mucoadhesive preparations have been examined using
radioisotopes and the fluorescent labeling techniques.
 GI Transit using Radio-Opaque Tablets
It is a simple procedure involving the use of radio-opaque markers, e.g.
barium sulfate, encapsulated in mucoadhesive tablets to determine the effects
of mucoadhesive polymers on GI transit time. Feces collection (using an
automated feces collection machine) and X-ray inspection provide a non-
invasive method of monitoring total GI residence time without affecting
normal GI motility. Mucoadhesives labeled with Cr-51, Tc- 99m, In-113m, or
I-123 have been used to study the transit of the tablets in the GI tract.
 Gamma Scintigraphy Technique
Gamma scintigraphy is a technique whereby the transit of a dosage form
through its intended site of delivery can be non-invasively imaged in vivo via
the judicious introduction of an appropriate short lived gamma emitting
radioisotope. The observed transit of the dosage form can then be correlated
with the rate and extent of drug absorption. The study emphasized the
importance of in vivo studies, because although chitosan exhibits an
outstanding mucoadhesion capacity in vitro, the retention time at the
absorption site in the human gastrointestinal tract was relatively short and not
sufficiently reproducible.
 X-RAY STUDIES
In this method administration of dosage form with a radio opaque substance
and subsequently locating the administered dosage form by means of X-Ray.
Aim is to figure out the In-vivo Mucoadhesive capacity of dosage form,
generally used for oral Mucoadhesive tablets.
CONCLUSION
The mucoadhesive drug delivery system is a very promising approach for
delivering the drugs which have narrow absorption window at the target site
to maximize their usefulness. With the introduction of a large number of new
drug molecules from drug discovery, mucoadhesive drug delivery will play
an even more important role in delivering these molecules. Improvements in
mucoadhesive based oral delivery and, in particular, the development of
novel, highly-effective and mucosa compatible polymers, are creating new
commercial and clinical opportunities
Mdds

More Related Content

What's hot

Implantable Drug Delivery System
Implantable Drug Delivery SystemImplantable Drug Delivery System
Implantable Drug Delivery Systemparesh bharodiya
 
Gastro retentive drug delivery system (GRDDS)
Gastro retentive drug delivery system (GRDDS)Gastro retentive drug delivery system (GRDDS)
Gastro retentive drug delivery system (GRDDS)Shweta Nehate
 
Bio Adhesive Drug Delivery System
Bio Adhesive Drug Delivery SystemBio Adhesive Drug Delivery System
Bio Adhesive Drug Delivery Systemoptimpharma
 
Activation modulated drug delivery systems
Activation modulated drug delivery systemsActivation modulated drug delivery systems
Activation modulated drug delivery systemsSonam Gandhi
 
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)Suraj Choudhary
 
Physicochemical and biological properties of sustained release formulations
Physicochemical and biological properties of sustained release formulationsPhysicochemical and biological properties of sustained release formulations
Physicochemical and biological properties of sustained release formulationsSonam Gandhi
 
Approaches for the design of transdermal drug delivery
Approaches for the design of transdermal drug deliveryApproaches for the design of transdermal drug delivery
Approaches for the design of transdermal drug deliverykvineetha8
 
Intrauterine & Intravaginal Drug Delivery System
Intrauterine & Intravaginal Drug Delivery SystemIntrauterine & Intravaginal Drug Delivery System
Intrauterine & Intravaginal Drug Delivery SystemPRASHANT DEORE
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery systemArshad Khan
 
1 gastroretentive drug delivery systems
1 gastroretentive drug delivery systems1 gastroretentive drug delivery systems
1 gastroretentive drug delivery systemsAkash Aher
 
Rate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery SystemRate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery SystemKailas Mali
 
Transdermal drug delivery system ppt
Transdermal drug delivery system pptTransdermal drug delivery system ppt
Transdermal drug delivery system pptDeepak Sarangi
 
Buccal drug delivery system
Buccal drug delivery systemBuccal drug delivery system
Buccal drug delivery systemPravin Chinchole
 
Gastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery SystemGastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery SystemDr Gajanan Sanap
 
Self micro-emulsifying drug delivery system (SMEDDS)
Self micro-emulsifying drug delivery system (SMEDDS)Self micro-emulsifying drug delivery system (SMEDDS)
Self micro-emulsifying drug delivery system (SMEDDS)Himal Barakoti
 
MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptx
  MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptx  MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptx
MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptxPawanDhamala1
 

What's hot (20)

Implantable Drug Delivery System
Implantable Drug Delivery SystemImplantable Drug Delivery System
Implantable Drug Delivery System
 
Gastro retentive drug delivery system (GRDDS)
Gastro retentive drug delivery system (GRDDS)Gastro retentive drug delivery system (GRDDS)
Gastro retentive drug delivery system (GRDDS)
 
Bio Adhesive Drug Delivery System
Bio Adhesive Drug Delivery SystemBio Adhesive Drug Delivery System
Bio Adhesive Drug Delivery System
 
Activation modulated drug delivery systems
Activation modulated drug delivery systemsActivation modulated drug delivery systems
Activation modulated drug delivery systems
 
Alzet osmotic pump
Alzet osmotic pumpAlzet osmotic pump
Alzet osmotic pump
 
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
 
Gastroretentive Drug Delivery System
Gastroretentive Drug Delivery SystemGastroretentive Drug Delivery System
Gastroretentive Drug Delivery System
 
Physicochemical and biological properties of sustained release formulations
Physicochemical and biological properties of sustained release formulationsPhysicochemical and biological properties of sustained release formulations
Physicochemical and biological properties of sustained release formulations
 
Mucoadhesive dds
Mucoadhesive ddsMucoadhesive dds
Mucoadhesive dds
 
Approaches for the design of transdermal drug delivery
Approaches for the design of transdermal drug deliveryApproaches for the design of transdermal drug delivery
Approaches for the design of transdermal drug delivery
 
Microspheres
MicrospheresMicrospheres
Microspheres
 
Intrauterine & Intravaginal Drug Delivery System
Intrauterine & Intravaginal Drug Delivery SystemIntrauterine & Intravaginal Drug Delivery System
Intrauterine & Intravaginal Drug Delivery System
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
1 gastroretentive drug delivery systems
1 gastroretentive drug delivery systems1 gastroretentive drug delivery systems
1 gastroretentive drug delivery systems
 
Rate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery SystemRate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery System
 
Transdermal drug delivery system ppt
Transdermal drug delivery system pptTransdermal drug delivery system ppt
Transdermal drug delivery system ppt
 
Buccal drug delivery system
Buccal drug delivery systemBuccal drug delivery system
Buccal drug delivery system
 
Gastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery SystemGastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery System
 
Self micro-emulsifying drug delivery system (SMEDDS)
Self micro-emulsifying drug delivery system (SMEDDS)Self micro-emulsifying drug delivery system (SMEDDS)
Self micro-emulsifying drug delivery system (SMEDDS)
 
MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptx
  MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptx  MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptx
MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptx
 

Similar to Mdds

Controlled drug delivery system
Controlled drug delivery systemControlled drug delivery system
Controlled drug delivery systemSushmitha002
 
OSMOTIC Control DDS EXPT..docx
OSMOTIC Control DDS EXPT..docxOSMOTIC Control DDS EXPT..docx
OSMOTIC Control DDS EXPT..docxSakshiSonawane6
 
Concept and systems of design for rate controlled drug delivery system
Concept and systems of design for rate controlled drug delivery systemConcept and systems of design for rate controlled drug delivery system
Concept and systems of design for rate controlled drug delivery systemEknath Babu T.B.
 
Buccal drug delivery pptx
Buccal drug delivery pptxBuccal drug delivery pptx
Buccal drug delivery pptxSreedhar Reddy
 
Buccal Drug Delivery System
Buccal Drug Delivery SystemBuccal Drug Delivery System
Buccal Drug Delivery SystemSwatiAbat
 
Polymer membrane permeation cdds
Polymer membrane permeation cddsPolymer membrane permeation cdds
Polymer membrane permeation cddsNazmul Islam
 
Applications of microsponge1
Applications of microsponge1Applications of microsponge1
Applications of microsponge1Madhavi Kuchekar
 
Buccal bioadhesive drug delivery system G1ppt
Buccal bioadhesive drug delivery system G1pptBuccal bioadhesive drug delivery system G1ppt
Buccal bioadhesive drug delivery system G1pptPadi Jeevanreddy
 
Model PPT-Proposal Presentation for ou.pptx
Model PPT-Proposal Presentation for ou.pptxModel PPT-Proposal Presentation for ou.pptx
Model PPT-Proposal Presentation for ou.pptxMadeeshShaik
 
Compression coated tablet techniques by prashik
Compression coated tablet techniques by prashikCompression coated tablet techniques by prashik
Compression coated tablet techniques by prashikprashikvaidya
 
Buccal drug delivery system
Buccal drug delivery systemBuccal drug delivery system
Buccal drug delivery systemrasika walunj
 
buccal drug delivery system
buccal drug delivery system buccal drug delivery system
buccal drug delivery system rasika walunj
 
buccal drug delivery system
buccal drug delivery systembuccal drug delivery system
buccal drug delivery systemrasikawalunj
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery systemSubhajit Dutta
 
Gastro retentive drug delivery system
Gastro retentive drug delivery systemGastro retentive drug delivery system
Gastro retentive drug delivery systemsuryanshsingh42
 
FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...
FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...
FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...ANURAG GROUP OF INSTITUTIONS
 
Advances in transmucosal drug delivery
Advances in transmucosal drug deliveryAdvances in transmucosal drug delivery
Advances in transmucosal drug deliveryGasper Fernandes
 

Similar to Mdds (20)

Controlled drug delivery system
Controlled drug delivery systemControlled drug delivery system
Controlled drug delivery system
 
Ndds
NddsNdds
Ndds
 
OSMOTIC Control DDS EXPT..docx
OSMOTIC Control DDS EXPT..docxOSMOTIC Control DDS EXPT..docx
OSMOTIC Control DDS EXPT..docx
 
Concept and systems of design for rate controlled drug delivery system
Concept and systems of design for rate controlled drug delivery systemConcept and systems of design for rate controlled drug delivery system
Concept and systems of design for rate controlled drug delivery system
 
Buccal drug delivery pptx
Buccal drug delivery pptxBuccal drug delivery pptx
Buccal drug delivery pptx
 
Buccal Drug Delivery System
Buccal Drug Delivery SystemBuccal Drug Delivery System
Buccal Drug Delivery System
 
Polymer membrane permeation cdds
Polymer membrane permeation cddsPolymer membrane permeation cdds
Polymer membrane permeation cdds
 
Applications of microsponge1
Applications of microsponge1Applications of microsponge1
Applications of microsponge1
 
Protein
ProteinProtein
Protein
 
Buccal bioadhesive drug delivery system G1ppt
Buccal bioadhesive drug delivery system G1pptBuccal bioadhesive drug delivery system G1ppt
Buccal bioadhesive drug delivery system G1ppt
 
Model PPT-Proposal Presentation for ou.pptx
Model PPT-Proposal Presentation for ou.pptxModel PPT-Proposal Presentation for ou.pptx
Model PPT-Proposal Presentation for ou.pptx
 
Compression coated tablet techniques by prashik
Compression coated tablet techniques by prashikCompression coated tablet techniques by prashik
Compression coated tablet techniques by prashik
 
Buccal drug delivery system
Buccal drug delivery systemBuccal drug delivery system
Buccal drug delivery system
 
buccal drug delivery system
buccal drug delivery system buccal drug delivery system
buccal drug delivery system
 
buccal drug delivery system
buccal drug delivery systembuccal drug delivery system
buccal drug delivery system
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
Gastro retentive drug delivery system
Gastro retentive drug delivery systemGastro retentive drug delivery system
Gastro retentive drug delivery system
 
Seminar ppt
Seminar pptSeminar ppt
Seminar ppt
 
FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...
FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...
FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...
 
Advances in transmucosal drug delivery
Advances in transmucosal drug deliveryAdvances in transmucosal drug delivery
Advances in transmucosal drug delivery
 

Recently uploaded

High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)MedicoseAcademics
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
Cure of patients which terminally ill.pdf
Cure of patients which terminally ill.pdfCure of patients which terminally ill.pdf
Cure of patients which terminally ill.pdfrg0000009
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 

Recently uploaded (20)

High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
Cure of patients which terminally ill.pdf
Cure of patients which terminally ill.pdfCure of patients which terminally ill.pdf
Cure of patients which terminally ill.pdf
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 

Mdds

  • 1. FORMULATION AND EVALUATION OF MUCOADHESIVE DRUG DELIVERY -BY MADHAVI GUPTA M.PHARM 1ST SEM PHARMACEUTICS
  • 2. What is Mucoadhesive drug delivery system?  Mucoadhesive drug delivery system interact with the mucus layer covering the mucosal epithelial surface, & mucin molecules & increase the residence time of the dosage form at the site of the absorption.  Mucoadhesive drug delivery system is a part of controlled delivery system.  MDDS have been developed for buccal, nasal, rectal and vaginal routes for both systemic and local effects.  Hydrophilic drugs having high mol. wt. such as peptides that cannot be administered and having a poor absorption, then in such type of cases Mucoadhesive Drug Delivery system is best choice.
  • 3. Why are we using Mucoadhesive drug delivery system(MDDS)?  MDDS prolong the residence time of the dosage form at the site of application or absorption.  Intimate contact of the dosage form with the underlying absorption .  Improve the therapeutic performance of drug.  Should not cause irritation.  High drug loading capacity.  Controlled drug release(preferably unidirectional release).
  • 5. Formulation design-  In case of both mucosal(local) & transmucosal (systemic) administration of conventional dosage are not able to assure therapeutic level.  In MDDS contain the following functional agents- • Mucoadhesive agents • Penetration enhancers • Enzyme inhibitors Mucoadhesive agents-  The polymer hydration & consequently the mucus cohesive properties that promote mucoadhesion .  Swelling should favor polymer chain flexibility & interpenetration b/w polymer & mucin chains.
  • 6. Ex-Poly acrylic acid (PAA) Polyvinyl alcohol (PVA) Sodium carboxy methyl cellulose (NaCMC) Sodium alginate HPMC HEC HPC  Various copolymer of acrylic acid such as acrylic acid, polyethylene glycol, mono methyl ether copolymer have also been studied. Penetration enhancers(PE)-  Substances that facilitate the permeation through mucosa are referred as permeation enhancers. They also required when a drug has to reach the systemic circulation to exert its action .  Must be non-irritant, non toxic &have a reversible effect.
  • 7.  Recently chitosan & its derivatives, polymers known for having Mucoadhesion properties are used, chitosan helps in transportation of drug throw paracellular pathway. List of Permeation Enhancer :-  Benzalkonium chloride  Dextran sulfate  Fatty acid  Propylene glycol  Menthol  Phosphatidyl choline  Polysorbate 80  Sodium EDTA
  • 8. Enzyme inhibitors-  Drug + enzyme inhibitors, improves the buccal absorption of drugs, specially peptides. Ex-1-Aprotinin 2-Bestatin 3-Puromycin  Bile salts stabilizes protein drugs by different mechanism effecting the activity of the enzymes, altering the conformation of the protein.  Chemical modification of chitosan with EDTA produces polymer conjugate chitosan –EDTA that is a very potent inhibitor of metallopeptidases (carboxypeptidase)
  • 10. A) Tablets Tablets are small, flat and oval, with a diameter of approximately 5–8 mm. They soften, adhere to the mucosa, and are retained in position until dissolution and/or release is complete. Mucoadhesive tablets, in general, have the potential to be used for controlled release drug delivery, but coupling of mucoadhesive properties to tablet has additional advantages, for example, it offers efficient absorption and enhanced bioavailability of the drugs due to a high surface to volume ratio and facilitates a much more intimate contact with the mucus layer. B) Matrix tablets- (a)Monolithic (b)two layered tablets  Monolithic- mixture of drug + swelling bioadhesive polymer bidirectional release & outer side coated with impermeable hyrophobic substances.
  • 11.  In two layered matrix tablets- Comprises an inner layer based on bioadhesive polymer &an outer non bioadhesive layer containing the drug for a bi-directional release but only local action. In case of systemic action outer layer is inert & act as a protective layer. C) Patches- Several different patch systems that adhere to the oral mucosa and are designed to deliver drugs have been developed. These patches are longer acting than solid forms such as tablets and lozenges and can produce sustained drug release for treating oral candidiasis and mucositis. Having greater patient compliance compared with tablets owing to their physical flexibility that causes only minor discomfort to the patient. C) Films- Mucoadhesive films may be preferred over adhesive tablets in terms of flexibility and comfort. Thin strips of polymeric films, capable of loading up to 20 mg of drugs, dissolve on the tongue in less than 30 sec and deliver drugs (which are able to cross the permeability barrier) directly to the blood
  • 12. supply for rapid treatment of conditions such as impotence, migraines, motion sickness, pain relief and nausea. An ideal film should be flexible, elastic &soft, without breaking due to stress from mouth movements. D) Gels & ointments- Semisolid dosage forms, such as gels and ointments, have the advantage of easy dispersion throughout the oral mucosa.. Poor retention of the gels at the site of application has been overcome by using mucoadhesive formulations. Mucoadhesive polymers, for example, sodium carboxymethylcellulose, carbopol, hyaluronic acid, and xanthan gum, undergo a phase change from liquid to semisolid. This change enhances the viscosity, which results in sustained and controlled release of drugs. Hydrogels are also a promising dosage form for buccal drug delivery. Gels applied to the oral mucosa have been trilled for the delivery of systemic analgesics, antihypertensive and drugs for treating cardiovascular disease as well as topical delivery of antifungal agents, anti-inflammatories and mucoprotective agents to the oral mucosa.
  • 13. EVALUATION STUDIES OF MUCOADHESIVE DRUG DELIVERY SYSTEM - A) In vitro/ex vivo tests • Methods determining tensile strength • Methods determining shear stress • Adhesion weight method • Fluorescent probe method • Flow channel method • Mechanical spectroscopic method • Falling liquid film method • Colloidal gold staining method • Viscometer method • Thumb method • Adhesion number • Electrical conductance • Swelling properties • In vitro drug release studies
  • 14. B) In vivo methods • Use of radioisotopes • Use of gamma scintigraphy • X - ray studies  Methods determining tensile strength Tensile and shear measure the mechanical properties of the system, whereas peel strength measures the peeling force. Texture profile analyzer is a commercial instrument which is used to measure the force required to remove bioadhesive films from excised tissue in vitro. For this test, a piece of animal mucous membrane was taken and tested for the force required to take away the formulation from a model membrane which consists of disc composed of mucin. The texture analyzer, operating in tensile test mode and coupled with a sliding lower platform, was also used to determine peel strength of similar formulations. On a movable platform the animal skin was placed and on top of it the bioadhesive film was placed, which was later on pulled vertically to determine the peel strength.
  • 15. Texture profile analyzer in bioadhesion test mode Determines peel strength of bioadhesive films
  • 16.  Methods determining shear stress The measurement of the shear stress gives a direct correlation to the adhesion strength. In a simple shear stress measurement based method two smooth, polished plexi glass boxes are taken. one block is fixed with adhesive Araldite on a glass plate, which is fixed on leveled table. The level is adjusted with the spirit level. To the upper block, a thread is tied and the thread is passed down through a pulley, the length of the thread from the pulley to the pan was 12 cm. At the end of the thread a pan of fixed is attached. More weights can be added to it. A recent method involves the measurement of mucoadhesion by use of a stainless steel rotating cylinder which is coated with freshly excised porcine intestinal mucosa to which polymer discs were attached. The cylinder is placed in a dissolution apparatus and rotated at 125 RPM. It is analysed every 30 mins for the attachment of the polymers discs.  Falling liquid film method In this method the mucous membrane is placed in a stainless steel cylindrical tube, which has been longitudinally cut. This support is placed inclined in a cylindrical cell with a temperature controlled at 37º. An isotonic solution is pumped through the mucous membrane and collected in a beaker.
  • 17.  Fluorescent probe method In this method the membrane lipid bilayer and membrane proteins are labeled with pyrene and fluorescein isothiocyanate, respectively. The cells are mixed with the mucoadhesive agents and changes in fluorescence spectra were monitored. This gives an indication of polymer binding and its influence on polymer adhesion  Flow Channel method The method is conducted to understand structural requirements for bioadhesion in order to design improved bioadhesive polymers for oral use. The membrane lipid bilayer and membrane proteins were labeled with pyrene and fluorescence isothiocyanate, respectively. The cells were then mixed with candidate bioadhesives and the change in florescence spectra was monitored. This gave an indication of polymer binding and its influence on polymer adhesion.  Swelling index The extent of swelling can be measured in terms of % weight gain by the dosage form. The swelling index is calculated using following formula.
  • 18. Where, S.I = Swelling index Wt = Weight of tablet at time t Wo = Weight of tablet before placing in the beaker  Colloidal gold staining method Colloidal gold staining technique is proposed for the study of bioadhesion. The technique employs red colloidal gold particles, which are adsorbed on mucin molecules to form mucin–gold conjugates, which upon interaction with bioadhesives hydrogels develops a red color on the surface. This can be quantified by measuring either the intensity on the hydrogel surface or the conjugates at 525 nm.  Viscometric method A simple viscometric method is used to quantify mucin – polymer bioadhesive bond strength. Viscosities of 15% w/v porcine gastric mucin dispersion in 0.1M HCl (pH 1) or 0.1M acetate buffer (pH 5.5) is measured with a Brookfield viscometer in the absence or presence of selected neutral, anionic, and cationic polymers. Viscosity components and the forces of bioadhesion are calculated.
  • 19.  Thumb method This is a very simple test used for the qualitative determination of peel adhesive strength of the polymer and is useful tool in the development of buccal adhesive delivery systems. The adhesiveness is measured by the difficulty of pulling the thumb from the adhesive as a function of the pressure and the contact time.  Adhesion number Adhesion number for mucoadhesive microspheres is determined as the ratio of the number of particles attached to the substrate to the total number of applied particles, expressed as a percentage. The adhesion strength increases with an increase in the adhesion number.  Electrical conductance The rotational viscometer was modified to determine electrical conductance of various semi-solid mucoadhesive ointments and found that the electrical conductance was low in the presence of adhesive material.
  • 20.  Mucoadhesive Strength Mucoadhesive strength of the dosage form can be measured on the modified physical balance. The apparatus consists of a modified double beam physical balance in which the right pan is replaced by a glass slide with copper wire and additional weight, to make the right side weight equal with left side pan. A Teflon block of fixed diameter and height is fabricated with an upward portion of 2 cm height and 1.5 cm diameter on one side. This is kept in beaker filled with buffer media 0.1N HCl pH 1.2, which is then placed below right side of the balance. Goat or rat stomach mucosa can be used as a model membrane and buffer media 0.1N HCl pH 1.2 can be used as moistening fluid. The one side of the dosage form is attached to the glass slide of the right arm of the balance and then the beaker is raised slowly until contact between goat mucosa and mucoadhesive dosage form is established. A preload of 10 g is placed on the slide for 5 min (preload time) to establish adhesion bonding between mucoadhesive dosage form and stomach mucosa. The preload and preload time are kept constant. After the completion of preload time, preload is removed from the glass slide and water is then added in the plastic bottle in left side arm by peristaltic pump at a constant rate of 100 drops per min. The addition of water is stopped when mucoadhesive dosage form is detached from the goat or rat stomach mucosa. The weight of water required to detach mucoadhesive dosage form from stomach mucosa is noted as mucoadhesive strength in grams.
  • 21. Figure : Mucoadhesion test assembly
  • 23.  Stability Studies The success of an effective formulation can be evaluated only through stability studies. The purpose of stability testing is to obtain a stable product which assures its safety and efficacy up to the end of shelf life at defined storage conditions and peak profile. ICH guidelines can be followed in this regard. In vivo Studies-  Measurement of the Residence Time- Measurements of the residence time of mucoadhesive at the application site provide quantitative information on their mucoadhesive properties. The GI transit times of many mucoadhesive preparations have been examined using radioisotopes and the fluorescent labeling techniques.
  • 24.  GI Transit using Radio-Opaque Tablets It is a simple procedure involving the use of radio-opaque markers, e.g. barium sulfate, encapsulated in mucoadhesive tablets to determine the effects of mucoadhesive polymers on GI transit time. Feces collection (using an automated feces collection machine) and X-ray inspection provide a non- invasive method of monitoring total GI residence time without affecting normal GI motility. Mucoadhesives labeled with Cr-51, Tc- 99m, In-113m, or I-123 have been used to study the transit of the tablets in the GI tract.  Gamma Scintigraphy Technique Gamma scintigraphy is a technique whereby the transit of a dosage form through its intended site of delivery can be non-invasively imaged in vivo via the judicious introduction of an appropriate short lived gamma emitting radioisotope. The observed transit of the dosage form can then be correlated with the rate and extent of drug absorption. The study emphasized the importance of in vivo studies, because although chitosan exhibits an outstanding mucoadhesion capacity in vitro, the retention time at the absorption site in the human gastrointestinal tract was relatively short and not sufficiently reproducible.
  • 25.  X-RAY STUDIES In this method administration of dosage form with a radio opaque substance and subsequently locating the administered dosage form by means of X-Ray. Aim is to figure out the In-vivo Mucoadhesive capacity of dosage form, generally used for oral Mucoadhesive tablets. CONCLUSION The mucoadhesive drug delivery system is a very promising approach for delivering the drugs which have narrow absorption window at the target site to maximize their usefulness. With the introduction of a large number of new drug molecules from drug discovery, mucoadhesive drug delivery will play an even more important role in delivering these molecules. Improvements in mucoadhesive based oral delivery and, in particular, the development of novel, highly-effective and mucosa compatible polymers, are creating new commercial and clinical opportunities